ARC Extends Reach in Medical Device Market On New License Agreement with Boston Scientific
SAN JOSE, Calif., and ST. ALBANS, England, March 24, 2009 – ARC International (LSE: ARK) a leading provider of consumer intellectual property (IP) to OEM and semiconductor companies worldwide today announced that Boston Scientific (NYSE: BSX) has extended their commitment to ARC® technology by taking a new license. A long-time ARC customer and worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties, Boston Scientific will use the new license in ultra-low power integrated circuits for implantable cardiac rhythm management device applications.
An expanding prevalence of heart, orthopedic, neurological, and visual disorders, coupled with ongoing improvements in the safety and effectiveness of electronic medical products, will promote the growth of implantable devices. According to recent market research, demand for implantable medical devices will grow close to 10 percent annually to $40 billion in 2011.
“Led by ARC and its low power microprocessor technology, the semiconductor industry is beginning to make a significant contribution to the growing medical device industry,” said Sean Redmond, vice president of worldwide field operations at ARC International. “We applaud Boston Scientific’s innovative application of our technology in improving healthcare in patients worldwide, and look forward to contributing to their continuing success.”
About ARC International plcARC International is a world leading provider of consumer IP to OEM and semiconductor companies globally. ARC’s award-winning, vertically integrated audio and video solutions enable high quality multimedia content to be captured, shared, and played on a wide range of electronics devices. ARC’s 150+ customers collectively ship hundreds of millions of ARC-Based™ chips annually in products such as Mobile TVs, Portable Media Players, WiFi-/WiMAX-enabled computers, flash storage, digital cameras, network appliances, and medical and government systems.
ARC International maintains a worldwide presence with corporate and research and development offices in San Jose and Lake Tahoe, Calif., St. Albans, England, St. Petersburg, Russia, and Hyderabad, India. For more information visit www.ARC.com. ARC International is listed on the London Stock Exchange as ARC International plc (LSE: ARK).
Related Semiconductor IP
- Simulation VIP for Ethernet UEC
- CAN-FD Controller
- Bluetooth® Low Energy 6.2 PHY IP with Channel Sounding
- Simulation VIP for UALink
- General use, integer-N 4GHz Hybrid Phase Locked Loop on TSMC 28HPC
Related News
- SCHLEIFRING Deploys Lattice ORT82G5 FPSC in Next-Generation Computed Tomography Medical System
- Altera FPGAs Enable Revolutionary Medical 3D Examination Technology
- AMIS Holdings Signs Agreement to Acquire Dspfactory Ltd to Strengthen DSP Design Capabilities for Medical and Industrial Markets
- New radio architecture meets medical implant designers' needs for higher performance and longer life
Latest News
- Quintauris releases RT-Europa, the first RISC-V Real-Time Platform for Automotive
- PQShield's PQCryptoLib-Core v1.0.2 Achieves CAVP Certification for a broad set of classical and post-quantum algorithms
- M31 Debuts at ICCAD 2025, Empowering the Next Generation of AI Chips with High-Performance, Low-Power IP
- Perceptia Begins Port of pPLL03 to Samsung 14nm Process Technology
- Spectral Design and Test Inc. and BAE Systems Announce Collaboration in RHBD Memory IP Development